Novartis

FDA approves the use of Entresto

Medicine & Technology Jul 08, 2015

The U.S. Food and Drug Administration (FDA) already approved the use of the latest heart failure drug from Novartis. The drug, known as Entresto, was found to be potent in reducing death and hospitalizations related to cardiovascular diseases.

Novartis Seeking Approval for Medication to Treat 'Smoker's Cough'

Jan 09, 2015

Novartis AG, a Swiss drug maker, is seeking U.S. regulatory approval for two new drugs designed to treat chronic obstructive pulmonary disease (COPD), otherwise known as "smoker's cough". Approval of the drugs could generate an additional $1.4 billion for the company, while helping chronic smokers breathe a little clearer in the process.